Cellular response to a glutathione S-transferase P1-1 activated prodrug

TER286 [gamma-glutamyl-alpha-amino-beta(2-ethyl-N,N,N',N'-tetrakis(2-chloro ethyl) phosphorodiamidate)-sulfonyl-propionyl-(R)-(-) phenylglycine] is a n ovel nitrogen mustard prodrug that is preferentially activated by glutathio ne S-transferase P1-1 (GSTP1-1). A human promyelocytic leukemia /TER286-res istant cell line was selected by chronic, long-term exposure to the prodrug . Although resistance was not readily achieved, eventually a 5-fold resista nt clone was isolated. Cross-resistance to melphalan occurred, but not to d oxorubicin (Adriamycin), taxol, and gamma-glutamyl-S-(benzyl)cysteinyl-R(-) -phenyl glycine diethyl ester, a GSTP1-1 inhibitor. The protein and transcr ipt levels and enzymatic activity of GSTP1-1 were reduced significantly in the selected resistant line. GST alpha levels were unchanged, and GST mu wa s undetectable. Although glutathione levels were elevated in human promyelo cytic leukemia/TER286 cells, no changes in the expression of thiol-related genes including gamma-glutamylcysteine synthetase, gamma-glutamyl transpept idase, or multidrug resistance protein were found. A 7-fold increase in cat alase expression in the resistant cell line indicated an adaptive response to oxidative and electrophilic stress, and this was also reflected in the l ower prevalence of drug-induced DNA single-strand breaks in the resistant c ells. Mouse embryo fibroblast GSTP1-1(-/-) cells exhibited 2-fold resistanc e to TER286 compared with GSTP1-1(+/+) cells. NIH3T3 cells transfected with combinations of gamma-GCS and multidrug resistance protein exhibited enhan ced resistance to TER286, although the degree of resistance was impaired by cotransfection of GSTP1-1. These results are consistent with responses in the TER286-resistant cells indicative of GSTP1-1-mediated mechanism of acti vation. In consequence, these data support the rationale that tumors expres sing high levels of GSTP1-1 will be more sensitive to the cytotoxic effects of the drug.